MAPK3 and breast carcinoma: Taking this into account, we assessed the influence of 2‐FF treatment on the activation of the two main MAPK pathways, ERK1/2 and p38 pathways, which have been described to be involved in breast cancer cell proliferation and migration (Chen et al., 2009; Zhang and Liu, 2002; Zhou et al., 2008).